@article{2182e2f128ae4c6e820edd5d32d7eabf,
title = "Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study",
abstract = "In this real-world evaluation of tafasitamab-lenalidomide (TL) in relapsed or refractory LBCL, patients receiving TL had higher rates of comorbidities and high-risk disease characteristics, and substantially lower progression-free survival and overall survival, compared with the L-MIND registration clinical trial for TL.",
author = "Qualls, {David A.} and Nicholas Lambert and Caimi, {Paolo F.} and Mwanasha Merrill and Priyanka Pullarkat and Godby, {Richard C.} and Bond, {David A.} and Wehmeyer, {Graham T.} and Jason Romancik and Behzad Amoozgar and Lori Leslie and Nastoupil, {Loretta J.} and Crombie, {Jennifer L.} and Abramson, {Jeremy S.} and Arushi Khurana and Nowakowski, {Grzegorz S.} and Kami Maddocks and Rutherford, {Sarah C.} and Brad Kahl and Michelle Okwali and Buege, {Michael J.} and Venkatraman Seshan and Batlevi, {Connie L.} and Gilles Salles",
note = "Publisher Copyright: {\textcopyright} 2023 The American Society of Hematology",
year = "2023",
month = dec,
day = "28",
doi = "10.1182/blood.2023021274",
language = "English (US)",
volume = "142",
pages = "2327--2331",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "26",
}